Rheumatoid factor seropositivity is inversely associated with oral contraceptive use in women without rheumatoid arthritis
- PMID: 16868018
- PMCID: PMC1798510
- DOI: 10.1136/ard.2006.060004
Rheumatoid factor seropositivity is inversely associated with oral contraceptive use in women without rheumatoid arthritis
Abstract
Objectives: To examine whether oral contraceptive use is associated with the presence of serum rheumatoid factor in women of reproductive age without rheumatoid arthritis.
Methods: 304 women selected from parents of children who were at increased risk of developing type 1 diabetes were studied, because they were enriched with the human leucocyte antigen-DR4 allele, a susceptibility marker for both type 1 diabetes and rheumatoid arthritis. Participants visited a clinic where blood was drawn for rheumatoid factor testing, and exposure data were collected via questionnaires. A medical history and joint examination were performed to rule out rheumatoid arthritis. Participants and examiners were unaware of the participants' rheumatoid factor status at the time of examination and questionnaire.
Results: Use of oral contraceptives at any time was inversely associated with rheumatoid factor positivity (adjusted odds ratio (OR) 0.2, 95% confidence interval (CI) 0.07 to 0.52) independent of age, education and smoking. Smoking > or = 20 pack-years was also associated with rheumatoid factor positivity (adjusted OR 56.38, 95% CI 4.31 to 736.98) compared with never smoking. Smoking 1-19 pack-years was not associated with a positive rheumatoid factor.
Conclusions: Our results suggest that oral contraceptive use, and possibly cigarette smoking, act early in the development of the immune dysregulation that occurs in rheumatoid arthritis.
Conflict of interest statement
Competing interests: None.
References
-
- Reveille J D. The genetic contribution to the pathogenesis of rheumatoid arthritis. Curr Opin Rheumatol 199810187–200. - PubMed
-
- Pladeval‐Villa M, Delclos G L, Varas C, Guyer H, Bruguet‐Tarradellas J, Anglada‐Arisa A. Controversy of oral contraceptives and risk of rheumatoid arthritis: meta‐analysis of conflicting studies and review of conflicting meta‐analyses with special emphasis on analysis of heterogeneity. Am J Epidemiol 19961441–14. - PubMed
-
- Spector T D, Hochberg M C. The protective effect of the oral contraceptive pill on rheumatoid arthritis: an overview of the analytic epidemiological studies using meta‐analysis. J Clin Epidemiol 1990431221–1230. - PubMed
-
- Brennan P, Bankhead C, Silman A, Symmons D. Oral contraceptives and rheumatoid arthritis: results from a primary care‐based incident case control study. Semin Arthritis Rheum 199726817–823. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P30 DK057516/DK/NIDDK NIH HHS/United States
- K23 AR051461/AR/NIAMS NIH HHS/United States
- K12 RR017707/RR/NCRR NIH HHS/United States
- R37 DK032493/DK/NIDDK NIH HHS/United States
- P30 DK57516/DK/NIDDK NIH HHS/United States
- R01 DK32493/DK/NIDDK NIH HHS/United States
- T32 AR007534/AR/NIAMS NIH HHS/United States
- N01 AR042218/AR/NIAMS NIH HHS/United States
- P30 AR47363/AR/NIAMS NIH HHS/United States
- T32 AR07534/AR/NIAMS NIH HHS/United States
- U19 AI050864/AI/NIAID NIH HHS/United States
- P60 AR47784/AR/NIAMS NIH HHS/United States
- U19 AI50864/AI/NIAID NIH HHS/United States
- P60 AR047784/AR/NIAMS NIH HHS/United States
- R01 DK032493/DK/NIDDK NIH HHS/United States
- P30 AR047363/AR/NIAMS NIH HHS/United States
- N01 AR42218/AR/NIAMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
